Search

Search Constraints

You searched for: Is Part Of Breast. Volume 36(2017)Supplement 1

Search Results

2. A Phase II Study of Metronomic Daily Oral Vinorelbine as First-Line Chemotherapy in Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer Resistant to Endocrine Therapy: Vinometro. (November 2017)

8. Advanced Stage Breast Cancer Lifestyle and Exercise (ABLE) Feasibility Study: Preliminary Results. (November 2017)